NCT02353299View on ClinicalTrials.gov

Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers

PHASE4CompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions
Healthy
Interventions
DRUG

Silenor 6 mg

Silenor 6 mg single nighttime dose.

DRUG

zolpidem 10 mg

Zolpidem 10 mg single nighttime dose

DRUG

Placebo

placebo single nighttime dose-1.5 hours

DRUG

Placebo

placebo single nighttime dose-4 hours

Trial Locations (1)

48377

Henry Ford Hospital Sleep Disorders & Research Center, Novi

Sponsors
All Listed Sponsors
collaborator

Henry Ford Hospital

OTHER

lead

Currax Pharmaceuticals

INDUSTRY

NCT02353299 - Assess the Effect of Zolpidem, Silenor & Placebo on Arousability, Ataxia/Balance & Cognition in Healthy Volunteers | Biotech Hunter | Biotech Hunter